Currently, with immunomagnetic isolation the scarce nDCs can be obtained for DC vaccination
Currently, with immunomagnetic isolation the scarce nDCs can be obtained for DC vaccination. plasmacytoid DCs were administered and showed encouraging immunological and clinical outcomes. Currently, also the combination of CD1c+ myeloid and plasmacytoid DCs as well as the intratumoral use of CD1c+ myeloid DCs is usually under investigation in the clinic. Isolation and culture strategies…